{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:42:51Z","timestamp":1789612971657,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T00:00:00Z","timestamp":1491523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T00:00:00Z","timestamp":1491523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bone loss and increased fracture are the devastating outcomes of chronic kidney disease-mineral and bone disorder (CKD-MBD) resulting from Klotho deficit-related mineral disturbance and hyperparathyroidism. Because Klotho down-regulation after renal injury is presumably affected by aberrant histone deacetylase (HDAC) activities, here we assess whether HDAC inhibition prevents Klotho loss and attenuates the CKD-associated bone complication in a mouse model of CKD-MBD. Mice fed adenine-containing diet developed the expected renal damage, a substantial Klotho loss and the deregulated key factors causally affecting bone remodeling, which were accompanied by a marked reduction of bone mineral density. Intriguingly, administration of a potent HDAC inhibitor trichostatin A (TSA) impressively alleviated the Klotho deficit and the observed alterations of serum, kidney and bone. TSA prevented Klotho loss by increasing the promoter-associated histone acetylation, therefore increasing Klotho transcription. More importantly the mice lacking Klotho by siRNA interference largely abolished the TSA protections against the serum and renal abnormalities, and the deranged bone micro-architectures. Thus, our study identified Klotho loss as a key event linking HDAC deregulation to the renal and bone injuries in CKD-MBD mice and demonstrated the therapeutic potentials of endogenous Klotho restoration by HDAC inhibition in treating CKD and the associated extrarenal complications.<\/jats:p>","DOI":"10.1038\/srep46195","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T11:14:26Z","timestamp":1491563666000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Klotho preservation via histone deacetylase inhibition attenuates chronic kidney disease-associated bone injury in mice"],"prefix":"10.1038","volume":"7","author":[{"given":"Wenjun","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangsen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,7]]},"reference":[{"key":"BFsrep46195_CR1","first-page":"1253","volume":"26","author":"H Komaba","year":"2016","unstructured":"Komaba, H. [The expanding concept of CKD-MBD]. Clinical calcium 26, 1253\u20131260, doi: CliCa160912531260 (2016).","journal-title":"Clinical calcium"},{"key":"BFsrep46195_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.disamonth.2015.08.003","volume":"61","author":"M Kochanek","year":"2015","unstructured":"Kochanek, M., Said, A. & Lerma, E. V. Mineral metabolism in chronic kidney disease. Disease-a-month: DM 61, 425\u2013433, doi: 10.1016\/j.disamonth.2015.08.003 (2015).","journal-title":"Disease-a-month: DM"},{"key":"BFsrep46195_CR3","first-page":"259","volume":"26","author":"Y Iwashita","year":"2016","unstructured":"Iwashita, Y., Iwashita, Y., Ito, T. & Shigematsu, T. [Treatment for CKD-MBD(Chronic Kidney Disease-Mineral and Bone Disorder)]. Clinical calcium 26, 259\u2013267, doi: CliCa1602259267 (2016).","journal-title":"Clinical calcium"},{"key":"BFsrep46195_CR4","first-page":"S136","volume":"23","author":"M-C Hu","year":"2010","unstructured":"Hu, M.-C., Kuro-o, M. & Moe, O. W. Klotho and kidney disease. Journal of nephrology 23, S136 (2010).","journal-title":"Journal of nephrology"},{"key":"BFsrep46195_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000346778","volume":"180","author":"MC Hu","year":"2013","unstructured":"Hu, M. C., Kuro-o, M. & Moe, O. W. Klotho and chronic kidney disease. Contributions to nephrology 180, 47\u201363, doi: 10.1159\/000346778 (2013).","journal-title":"Contributions to nephrology"},{"key":"BFsrep46195_CR6","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1126\/science.1112766","volume":"309","author":"H Kurosu","year":"2005","unstructured":"Kurosu, H. et al. Suppression of aging in mice by the hormone Klotho. Science 309, 1829\u20131833, doi: 10.1126\/science.1112766 (2005).","journal-title":"Science"},{"key":"BFsrep46195_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/MNH.0b013e32836213ee","volume":"22","author":"H Olauson","year":"2013","unstructured":"Olauson, H. & Larsson, T. E. FGF23 and Klotho in chronic kidney disease. Curr Opin Nephrol Hypertens 22, 397\u2013404, doi: 10.1097\/MNH.0b013e32836213ee (2013).","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"BFsrep46195_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1172\/JCI5705","volume":"104","author":"H Kawaguchi","year":"1999","unstructured":"Kawaguchi, H. et al. Independent impairment of osteoblast and osteoclast differentiation in klotho mouse exhibiting low-turnover osteopenia. Journal of Clinical Investigation 104, 229 (1999).","journal-title":"Journal of Clinical Investigation"},{"key":"BFsrep46195_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bone.2013.08.008","volume":"57","author":"M Sasaki","year":"2013","unstructured":"Sasaki, M. et al. Altered distribution of bone matrix proteins and defective bone mineralization in klotho-deficient mice. Bone 57, 206\u2013219, doi: 10.1016\/j.bone.2013.08.008 (2013).","journal-title":"Bone"},{"key":"BFsrep46195_CR10","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa, I. et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444, 770\u2013774, doi: 10.1038\/nature05315 (2006).","journal-title":"Nature"},{"key":"BFsrep46195_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000331737","volume":"28","author":"M Dermaku-Sopjani","year":"2011","unstructured":"Dermaku-Sopjani, M. et al. Downregulation of NaPi-IIa and NaPi-IIb Na-coupled phosphate transporters by coexpression of Klotho. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology 28, 251\u2013258, doi: 10.1159\/000331737 (2011).","journal-title":"Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology"},{"key":"BFsrep46195_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1210\/er.2013-1079","volume":"36","author":"Y Xu","year":"2015","unstructured":"Xu, Y. & Sun, Z. Molecular basis of Klotho: from gene to function in aging. Endocrine reviews 36, 174\u2013193, doi: 10.1210\/er.2013-1079 (2015).","journal-title":"Endocrine reviews"},{"key":"BFsrep46195_CR13","doi-asserted-by":"publisher","first-page":"8655","DOI":"10.1074\/jbc.M110.174037","volume":"286","author":"S Doi","year":"2011","unstructured":"Doi, S. et al. Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice. J Biol Chem 286, 8655\u20138665, doi: 10.1074\/jbc.M110.174037 (2011).","journal-title":"J Biol Chem"},{"key":"BFsrep46195_CR14","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1006\/bbrc.2000.4226","volume":"280","author":"N Koh","year":"2001","unstructured":"Koh, N. et al. Severely reduced production of klotho in human chronic renal failure kidney. Biochemical and biophysical research communications 280, 1015\u20131020, doi: 10.1006\/bbrc.2000.4226 (2001).","journal-title":"Biochemical and biophysical research communications"},{"key":"BFsrep46195_CR15","doi-asserted-by":"publisher","first-page":"e86301","DOI":"10.1371\/journal.pone.0086301","volume":"9","author":"H Sakan","year":"2014","unstructured":"Sakan, H. et al. Reduced Renal alpha-Klotho Expression in CKD Patients and Its Effect on Renal Phosphate Handling and Vitamin D Metabolism. PLoS One 9, e86301, doi: 10.1371\/journal.pone.0086301 (2014).","journal-title":"PLoS One"},{"key":"BFsrep46195_CR16","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1161\/01.HYP.0000013734.33441.EA","volume":"39","author":"H Mitani","year":"2002","unstructured":"Mitani, H. et al. In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage. Hypertension 39, 838\u2013843 (2002).","journal-title":"Hypertension"},{"key":"BFsrep46195_CR17","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1073\/pnas.0611079104","volume":"104","author":"Y Haruna","year":"2007","unstructured":"Haruna, Y. et al. Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proceedings of the National Academy of Sciences of the United States of America 104, 2331\u20132336, doi: 10.1073\/pnas.0611079104 (2007).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFsrep46195_CR18","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/ki.2015.160","volume":"88","author":"Y Zhao","year":"2015","unstructured":"Zhao, Y. et al. Mammalian target of rapamycin signaling inhibition ameliorates vascular calcification via Klotho upregulation. Kidney international 88, 711\u2013721 (2015).","journal-title":"Kidney international"},{"key":"BFsrep46195_CR19","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1096\/fj.12-211631","volume":"26","author":"M Azuma","year":"2012","unstructured":"Azuma, M. et al. Promoter methylation confers kidney-specific expression of the Klotho gene. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 26, 4264\u20134274, doi: 10.1096\/fj.12-211631 (2012).","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"BFsrep46195_CR20","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1681\/asn.2010101073","volume":"22","author":"JA Moreno","year":"2011","unstructured":"Moreno, J. A. et al. The Inflammatory Cytokines TWEAK and TNF Reduce Renal Klotho Expression through NF B. Journal of the American Society of Nephrology 22, 1315\u20131325, doi: 10.1681\/asn.2010101073 (2011).","journal-title":"Journal of the American Society of Nephrology"},{"key":"BFsrep46195_CR21","doi-asserted-by":"publisher","first-page":"pe76","DOI":"10.1126\/scisignal.297pe76","volume":"2","author":"KL Norris","year":"2009","unstructured":"Norris, K. L., Lee, J. Y. & Yao, T. P. Acetylation goes global: the emergence of acetylation biology. Science signaling 2, pe76, doi: 10.1126\/scisignal.297pe76 (2009).","journal-title":"Science signaling"},{"key":"BFsrep46195_CR22","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1126\/science.1062374","volume":"293","author":"L Chen","year":"2001","unstructured":"Chen, L., Fischle, W., Verdin, E. & Greene, W. C. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 293, 1653\u20131657, doi: 10.1126\/science.1062374 (2001).","journal-title":"Science"},{"key":"BFsrep46195_CR23","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0092-8674(00)80521-8","volume":"90","author":"W Gu","year":"1997","unstructured":"Gu, W. & Roeder, R. G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595\u2013606 (1997).","journal-title":"Cell"},{"key":"BFsrep46195_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.biocel.2008.08.027","volume":"41","author":"S Spange","year":"2009","unstructured":"Spange, S., Wagner, T., Heinzel, T. & Kramer, O. H. Acetylation of non-histone proteins modulates cellular signalling at multiple levels. The international journal of biochemistry & cell biology 41, 185\u2013198, doi: 10.1016\/j.biocel.2008.08.027 (2009).","journal-title":"The international journal of biochemistry & cell biology"},{"key":"BFsrep46195_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fphys.2015.00121","volume":"6","author":"N Liu","year":"2015","unstructured":"Liu, N. & Zhuang, S. Treatment of chronic kidney diseases with histone deacetylase inhibitors. Frontiers in physiology 6, 121, doi: 10.3389\/fphys.2015.00121 (2015).","journal-title":"Frontiers in physiology"},{"key":"BFsrep46195_CR26","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.2337\/db13-1810","volume":"63","author":"R Liu","year":"2014","unstructured":"Liu, R. et al. Role of transcription factor acetylation in diabetic kidney disease. Diabetes 63, 2440\u20132453 (2014).","journal-title":"Diabetes"},{"key":"BFsrep46195_CR27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.trim.2010.02.003","volume":"23","author":"F Kinugasa","year":"2010","unstructured":"Kinugasa, F. et al. Prevention of renal interstitial fibrosis via histone deacetylase inhibition in rats with unilateral ureteral obstruction. Transplant immunology 23, 18\u201323 (2010).","journal-title":"Transplant immunology"},{"key":"BFsrep46195_CR28","doi-asserted-by":"publisher","first-page":"F996","DOI":"10.1152\/ajprenal.00282.2009","volume":"297","author":"M Pang","year":"2009","unstructured":"Pang, M. et al. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. American Journal of Physiology-Renal Physiology 297, F996\u2013F1005 (2009).","journal-title":"American Journal of Physiology-Renal Physiology"},{"key":"BFsrep46195_CR29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1172\/jci16153","volume":"111","author":"N Mishra","year":"2003","unstructured":"Mishra, N., Reilly, C. M., Brown, D. R., Ruiz, P. & Gilkeson, G. S. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr\/lpr mouse. The Journal of clinical investigation 111, 539\u2013552, doi: 10.1172\/jci16153 (2003).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep46195_CR30","doi-asserted-by":"publisher","first-page":"e79856","DOI":"10.1371\/journal.pone.0079856","volume":"8","author":"J-C Dussaule","year":"2013","unstructured":"Dussaule, J.-C. et al. Elevated Klotho Promoter Methylation Is Associated with Severity of Chronic Kidney Disease. PLoS ONE 8, e79856, doi: 10.1371\/journal.pone.0079856 (2013).","journal-title":"PLoS ONE"},{"key":"BFsrep46195_CR31","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/ki.2011.445","volume":"81","author":"CY Sun","year":"2012","unstructured":"Sun, C. Y., Chang, S. C. & Wu, M. S. Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation. Kidney international 81, 640\u2013650, doi: 10.1038\/ki.2011.445 (2012).","journal-title":"Kidney international"},{"key":"BFsrep46195_CR32","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000183992","volume":"44","author":"T Yokozawa","year":"1986","unstructured":"Yokozawa, T., Zheng, P. D., Oura, H. & Koizumi, F. Animal model of adenine-induced chronic renal failure in rats. Nephron 44, 230\u2013234 (1986).","journal-title":"Nephron"},{"key":"BFsrep46195_CR33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.kint.2016.07.040","volume":"91","author":"Q Zhang","year":"2017","unstructured":"Zhang, Q. et al. Rhein reverses Klotho repression via promoter demethylation and protects against kidney and bone injuries in mice with chronic kidney disease. Kidney International 91, 144\u2013156, doi: 10.1016\/j.kint.2016.07.040 (2017).","journal-title":"Kidney International"},{"key":"BFsrep46195_CR34","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/ndt\/gfi273","volume":"21","author":"K Tamagaki","year":"2006","unstructured":"Tamagaki, K. et al. Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association 21, 651\u2013659, doi: 10.1093\/ndt\/gfi273 (2006).","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"BFsrep46195_CR35","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.vascn.2013.05.001","volume":"68","author":"BH Ali","year":"2013","unstructured":"Ali, B. H. et al. New model for adenine-induced chronic renal failure in mice, and the effect of gum acacia treatment thereon: comparison with rats. Journal of pharmacological and toxicological methods 68, 384\u2013393 (2013).","journal-title":"Journal of pharmacological and toxicological methods"},{"key":"BFsrep46195_CR36","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1471-2369-14-116","volume":"14","author":"T Jia","year":"2013","unstructured":"Jia, T. et al. A novel model of adenine-induced tubulointerstitial nephropathy in mice. BMC nephrology 14, 116, doi: 10.1186\/1471-2369-14-116 (2013).","journal-title":"BMC nephrology"},{"key":"BFsrep46195_CR37","doi-asserted-by":"crossref","unstructured":"Ferrari, G. O. et al. Mineral bone disorder in chronic kidney disease: head-to-head comparison of the 5\/6 nephrectomy and adenine models. BMC nephrology 15, doi: 10.1186\/1471-2369-15-69 (2014).","DOI":"10.1186\/1471-2369-15-69"},{"key":"BFsrep46195_CR38","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/jbmr.485","volume":"26","author":"SM Moe","year":"2011","unstructured":"Moe, S. M. et al. The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 26, 2672\u20132681, doi: 10.1002\/jbmr.485 (2011).","journal-title":"Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research"},{"key":"BFsrep46195_CR39","doi-asserted-by":"publisher","first-page":"F729","DOI":"10.1152\/ajprenal.00086.2009","volume":"297","author":"H Noh","year":"2009","unstructured":"Noh, H. et al. Histone deacetylase-2 is a key regulator of diabetes-and transforming growth factor-\u03b21-induced renal injury. American Journal of Physiology-Renal Physiology 297, F729\u2013F739 (2009).","journal-title":"American Journal of Physiology-Renal Physiology"},{"key":"BFsrep46195_CR40","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/ki.2014.111","volume":"86","author":"X Wang","year":"2014","unstructured":"Wang, X. et al. Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy. Kidney International 86, 712\u2013725, doi: 10.1038\/ki.2014.111 (2014).","journal-title":"Kidney International"},{"key":"BFsrep46195_CR41","doi-asserted-by":"publisher","first-page":"21819","DOI":"10.1073\/pnas.0911987106","volume":"106","author":"Y Cao","year":"2009","unstructured":"Cao, Y. et al. Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models. Proceedings of the National Academy of Sciences 106, 21819\u201321824 (2009).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"BFsrep46195_CR42","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.kint.2016.01.026","volume":"90","author":"L Cebotaru","year":"2016","unstructured":"Cebotaru, L. et al. Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease. Kidney International 90, 90\u201399, doi: 10.1016\/j.kint.2016.01.026 (2016).","journal-title":"Kidney International"},{"key":"BFsrep46195_CR43","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/ncb2167","volume":"13","author":"F Liu","year":"2011","unstructured":"Liu, F., Wu, S., Ren, H. & Gu, J. Klotho suppresses RIG-I-mediated senescence-associated inflammation. Nature cell biology 13, 254\u2013262 (2011).","journal-title":"Nature cell biology"},{"key":"BFsrep46195_CR44","doi-asserted-by":"crossref","unstructured":"Maltese, G. et al. The anti-ageing hormone klotho induces Nrf2-mediated antioxidant defences in human aortic smooth muscle cells. Journal of Cellular and Molecular Medicine doi: 10.1111\/jcmm.12996 (2016).","DOI":"10.1111\/jcmm.12996"},{"key":"BFsrep46195_CR45","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1681\/asn.2007091040","volume":"19","author":"T Marumo","year":"2008","unstructured":"Marumo, T., Hishikawa, K., Yoshikawa, M. & Fujita, T. Epigenetic regulation of BMP7 in the regenerative response to ischemia. Journal of the American Society of Nephrology: JASN 19, 1311\u20131320, doi: 10.1681\/asn.2007091040 (2008).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"BFsrep46195_CR46","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s40620-016-0284-7","volume":"29","author":"K Wei","year":"2016","unstructured":"Wei, K., Yin, Z. & Xie, Y. Roles of the kidney in the formation, remodeling and repair of bone. Journal of Nephrology 29, 349\u2013357, doi: 10.1007\/s40620-016-0284-7 (2016).","journal-title":"Journal of Nephrology"},{"key":"BFsrep46195_CR47","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1046\/j.1523-1755.2003.00035.x","volume":"63","author":"S Wang","year":"2003","unstructured":"Wang, S. et al. Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy11Professor Robert Chevalier served as a guest editor for this paper. Kidney International 63, 2037\u20132049, doi: 10.1046\/j.1523-1755.2003.00035.x (2003).","journal-title":"Kidney International"},{"key":"BFsrep46195_CR48","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1359\/jbmr.050813","volume":"20","author":"TM Schroeder","year":"2005","unstructured":"Schroeder, T. M. & Westendorf, J. J. Histone Deacetylase Inhibitors Promote Osteoblast Maturation. Journal of Bone and Mineral Research 20, 2254\u20132263, doi: 10.1359\/jbmr.050813 (2005).","journal-title":"Journal of Bone and Mineral Research"},{"key":"BFsrep46195_CR49","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1182\/blood-2002-08-2622","volume":"101","author":"MM Rahman","year":"2003","unstructured":"Rahman, M. M. Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages. Blood 101, 3451\u20133459, doi: 10.1182\/blood-2002-08-2622 (2003).","journal-title":"Blood"},{"key":"BFsrep46195_CR50","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3390\/ijms17091446","volume":"17","author":"C Ghayor","year":"2016","unstructured":"Ghayor, C. & Weber, F. Epigenetic Regulation of Bone Remodeling and Its Impacts in Osteoporosis. International Journal of Molecular Sciences 17, 1446, doi: 10.3390\/ijms17091446 (2016).","journal-title":"International Journal of Molecular Sciences"},{"key":"BFsrep46195_CR51","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.bone.2011.06.025","volume":"49","author":"Y Rhee","year":"2011","unstructured":"Rhee, Y. et al. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo . Bone 49, 636\u2013643, doi: 10.1016\/j.bone.2011.06.025 (2011).","journal-title":"Bone"},{"key":"BFsrep46195_CR52","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3109\/03008207.2012.753879","volume":"54","author":"A Raimann","year":"2013","unstructured":"Raimann, A. et al. Fibroblast Growth Factor 23 and Klotho Are Present in the Growth Plate. Connective Tissue Research 54, 108\u2013117, doi: 10.3109\/03008207.2012.753879 (2013).","journal-title":"Connective Tissue Research"},{"key":"BFsrep46195_CR53","doi-asserted-by":"crossref","unstructured":"Lindberg, K. et al. The Kidney Is the Principal Organ Mediating Klotho Effects. Journal of the American Society of Nephrology: JASN doi: 10.1681\/ASN.2013111209 (2014).","DOI":"10.1681\/ASN.2013111209"},{"key":"BFsrep46195_CR54","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/ki.2011.445","volume":"81","author":"C-Y Sun","year":"2012","unstructured":"Sun, C.-Y., Chang, S.-C. & Wu, M.-S. Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation. Kidney International 81, 640\u2013650, doi: 10.1038\/ki.2011.445 (2012).","journal-title":"Kidney International"},{"key":"BFsrep46195_CR55","doi-asserted-by":"publisher","first-page":"157","DOI":"10.5173\/ceju.2015.453","volume":"68","author":"AH la Rosa","year":"2015","unstructured":"la Rosa, A. H., Acker, M., Swain, S. & Manoharan, M. The role of epigenetics in kidney malignancies. Central European journal of urology 68, 157\u2013164, doi: 10.5173\/ceju.2015.453 (2015).","journal-title":"Central European journal of urology"},{"key":"BFsrep46195_CR56","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2217\/epi.14.80","volume":"7","author":"T Hamidi","year":"2015","unstructured":"Hamidi, T., Singh, A. K. & Chen, T. Genetic alterations of DNA methylation machinery in human diseases. Epigenomics 7, 247\u2013265, doi: 10.2217\/epi.14.80 (2015).","journal-title":"Epigenomics"},{"key":"BFsrep46195_CR57","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.semnephrol.2013.05.008","volume":"33","author":"MR Wing","year":"2013","unstructured":"Wing, M. R., Ramezani, A., Gill, H. S., Devaney, J. M. & Raj, D. S. Epigenetics of progression of chronic kidney disease: fact or fantasy? Seminars in nephrology 33, 363\u2013374, doi: 10.1016\/j.semnephrol.2013.05.008 (2013).","journal-title":"Seminars in nephrology"},{"key":"BFsrep46195_CR58","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/ki.2008.244","volume":"74","author":"H Zhang","year":"2008","unstructured":"Zhang, H. et al. Klotho is a target gene of PPAR-gamma. Kidney international 74, 732\u2013739, doi: 10.1038\/ki.2008.244 (2008).","journal-title":"Kidney international"},{"key":"BFsrep46195_CR59","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1210\/en.2005-1529","volume":"147","author":"Y Chihara","year":"2006","unstructured":"Chihara, Y. et al. Klotho protein promotes adipocyte differentiation. Endocrinology 147, 3835\u20133842, doi: 10.1210\/en.2005-1529 (2006).","journal-title":"Endocrinology"},{"key":"BFsrep46195_CR60","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.freeradbiomed.2016.01.011","volume":"92","author":"T Qin","year":"2016","unstructured":"Qin, T. et al. Sinomenine activation of Nrf2 signaling prevents hyperactive inflammation and kidney injury in a mouse model of obstructive nephropathy. Free radical biology & medicine 92, 90\u201399, doi: 10.1016\/j.freeradbiomed.2016.01.011 (2016).","journal-title":"Free radical biology & medicine"},{"key":"BFsrep46195_CR61","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00109-015-1340-9","volume":"94","author":"L Liu","year":"2016","unstructured":"Liu, L., Lin, W., Zhang, Q., Cao, W. & Liu, Z. TGF-\u03b2 induces miR-30d down-regulation and podocyte injury through Smad2\/3 and HDAC3-associated transcriptional repression. Journal of Molecular Medicine 94, 291\u2013300, doi: 10.1007\/s00109-015-1340-9 (2016).","journal-title":"Journal of Molecular Medicine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep46195.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep46195","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/srep46195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/srep46195.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T23:19:40Z","timestamp":1671837580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep46195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,7]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,5,30]]}},"alternative-id":["BFsrep46195"],"URL":"https:\/\/doi.org\/10.1038\/srep46195","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,7]]},"assertion":[{"value":"25 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46195"}}